David Shyr, MD, on Incorporating AI Into Medicine
The clinical assistant professor at Stanford Medicine discussed potential applications for machine learning in analyzing data in medicine.
David Shyr, MD, on ASH 2023 Highlights, Further Research for Nula-Cel SCD Therapy
The clinical assistant professor at Stanford Medicine also shared his excitement on the recent approvals of lovo-cel and exa-cel.
David Shyr, MD, on Surprising Findings With CRISPR Cell Therapy Nula-Cel in Sickle Cell Disease
The clinical assistant professor at Stanford Medicine discussed outcomes of the first patient that received KMAU-011.